Laura Vidal
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- PARP inhibition in cancer therapy
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
Papers in
- Co-authors
- Maura L. Gillison (1 shared paper)Johann S. de Bono (8 shared papers)James Spicer (5 shared papers)L. Leibovici (1 shared paper)Anat Gafter‐Gvili (1 shared paper)Irit Ben‐Aharon (1 shared paper)Luisa Bonilla (1 shared paper)Salomon M. Stemmer (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Annals of Oncology (3 papers)Clinical Cancer Research (3 papers)Clinical & Translational Oncology (2 papers)Journal of Clinical Medicine (2 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Laura Vidal
56 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 101
- Oncology 641
- Otorhinolaryngology 100
- Reproductive Medicine 121
- Internal Medicine 47
- Cancer Research 185
Countries citing papers authored by Laura Vidal
This map shows the geographic impact of Laura Vidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Vidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Vidal more than expected).
Fields of papers citing papers by Laura Vidal
This network shows the impact of papers produced by Laura Vidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Vidal. The network helps show where Laura Vidal may publish in the future.
Co-authors
The 25 scholars most cited alongside Laura Vidal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 298 | |
| 2 | 2010 | 145 | |
| 3 | 2008 | 125 | |
| 4 | 2008 | 89 | |
| 5 | 2022 | 88 | |
| 6 | 2010 | 69 | |
| 7 | 2015 | 59 | |
| 8 | 2004 | 57 | |
| 9 | 2005 | 52 | |
| 10 | 2021 | 47 | |
| 11 | 2011 | 45 | |
| 12 | 2010 | 43 | |
| 13 | 2009 | 36 | |
| 14 | 2021 | 31 | |
| 15 | 2010 | 31 | |
| 16 | 2009 | 30 | |
| 17 | 2006 | 29 | |
| 18 | 2018 | 27 | |
| 19 | 2020 | 23 | |
| 20 | 2023 | 20 |
About Laura Vidal
Laura Vidal is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Reproductive Medicine and Cardiology and Cardiovascular Medicine, having authored 68 papers that have together received 1.6k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (8 papers), Pancreatitis Pathology and Treatment (7 papers), Cardiac Valve Diseases and Treatments (4 papers), PARP inhibition in cancer therapy (4 papers), Infective Endocarditis Diagnosis and Management (4 papers), Endometrial and Cervical Cancer Treatments (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers) and Cardiac Structural Anomalies and Repair (3 papers). The work is most often cited by research in Oncology (641 citations), Otorhinolaryngology (100 citations), Reproductive Medicine (121 citations), Internal Medicine (47 citations) and Cancer Research (185 citations). Laura Vidal has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Maura L. Gillison, Johann S. de Bono, James Spicer, L. Leibovici, Anat Gafter‐Gvili, Irit Ben‐Aharon, Luisa Bonilla, Salomon M. Stemmer, Timothy A. Yap and Ruth Plummer. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, Clinical & Translational Oncology and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.